Clinical Trials of New Cancer Drugs 'Frequently Flawed'

11:30 EDT 2 May 2019 | Medscape

Many randomized clinical trials that lead to approvals for cancer drugs have suboptimal control arms, biasing outcomes in favor of the experimental arm.
Medscape Medical News

Original Article: Clinical Trials of New Cancer Drugs 'Frequently Flawed'


More From BioPortfolio on "Clinical Trials of New Cancer Drugs 'Frequently Flawed'"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...